We are live on ! Find out more
KMWM

Keudell/Morrison Wealth Management Portfolio holdings

AUM $529M
This Fund
S&P 500
This Quarter Est. Return
+18.72%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$121M
AUM Growth
+$18.7M
Cap. Flow
+$2.16M
Cap. Flow %
1.79%
Top 10 Hldgs %
27.36%
Holding
152
New
16
Increased
66
Reduced
47
Closed
11

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$1.09M
2
USB icon
US Bancorp
USB
+$740K
3
ZTS icon
Zoetis
ZTS
+$708K
4
WY icon
Weyerhaeuser
WY
+$672K
5
MPT
Medical Properties Trust
MPT
+$665K

Sector Composition

Rank Sector Weight
1 Technology 21.04%
2 Healthcare 15.07%
3 Communication Services 12.7%
4 Financials 9.56%
5 Consumer Staples 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LRCX icon
101
Lam Research
LRCX
$390B
$342K 0.28%
10,580
-180
-2% -$4.91K
VYM icon
102
Vanguard High Dividend Yield ETF
VYM
$82.8B
$339K 0.28%
+4,300
New +$334K
KMI icon
103
Kinder Morgan
KMI
$68.7B
$336K 0.28%
22,173
-770
-3% -$11.7K
DVY icon
104
iShares Select Dividend ETF
DVY
$23.6B
$335K 0.28%
4,150
+300
+8% +$24K
NVS icon
105
Novartis
NVS
$297B
$334K 0.28%
3,823
+643
+20% +$55.5K
AVGO icon
106
Broadcom
AVGO
$2.04T
$331K 0.27%
10,500
+650
+7% +$18.2K
GIS icon
107
General Mills
GIS
$19.7B
$331K 0.27%
5,371
-319
-6% -$19.2K
SNY icon
108
Sanofi
SNY
$104B
$330K 0.27%
6,468
+514
+9% +$25K
KMB icon
109
Kimberly-Clark
KMB
$36.5B
$322K 0.27%
2,281
-890
-28% -$123K
AZN icon
110
AstraZeneca
AZN
$250B
$315K 0.26%
2,975
+57
+2% +$5.89K
IWN icon
111
iShares Russell 2000 Value ETF
IWN
$14.6B
$292K 0.24%
3,000
DGRO icon
112
iShares Core Dividend Growth ETF
DGRO
$43.5B
$289K 0.24%
+7,685
New +$279K
CTXS
113
DELISTED
Citrix Systems Inc
CTXS
$278K 0.23%
1,877
-38
-2% -$5.47K
IT icon
114
Gartner
IT
$11.7B
$276K 0.23%
2,278
MMM icon
115
3M
MMM
$94.3B
$275K 0.23%
+2,112
New +$266K
TSM icon
116
TSMC
TSM
$2.18T
$275K 0.23%
4,843
-218
-4% -$11.5K
DGX icon
117
Quest Diagnostics
DGX
$26.3B
$271K 0.22%
+2,377
New +$252K
C icon
118
Citigroup
C
$226B
$269K 0.22%
5,257
+271
+5% +$12.9K
AKAM icon
119
Akamai
AKAM
$15.9B
$261K 0.22%
2,437
+24
+1% +$2.41K
BIIB icon
120
Biogen
BIIB
$30.7B
$261K 0.22%
974
-83
-8% -$24.9K
EPD icon
121
Enterprise Products Partners
EPD
$81.7B
$246K 0.2%
13,535
+868
+7% +$15.5K
BABA icon
122
Alibaba
BABA
$308B
$244K 0.2%
+1,129
New +$235K
NVDA icon
123
NVIDIA
NVDA
$5.42T
$244K 0.2%
+25,640
New +$207K
CVS icon
124
CVS Health
CVS
$122B
$227K 0.19%
3,498
+6
+0.2% +$378
ASML icon
125
ASML
ASML
$669B
$224K 0.19%
+609
New +$191K

Similar funds

Keudell/Morrison Wealth Management's Q2 2020 Portfolio in Review

As of Q2 2020, Keudell/Morrison Wealth Management held 152 positions worth $121M, up 18% from $102M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Keudell/Morrison Wealth Management's Q2 2020 filing shows 16 new, 66 increased, 47 reduced and 11 closed positions. Its largest new stake was Invesco QQQ Trust: 4,870 shares worth $1.21M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $1.15M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Healthcare and Communication Services.

  • Keudell/Morrison Wealth Management's largest Q2 2020 buy was Invesco QQQ Trust: 4,870 shares worth $1.21M.
  • Keudell/Morrison Wealth Management added most to US Bancorp in Q2 2020, an estimated $740K increase.
  • Keudell/Morrison Wealth Management's biggest Q2 2020 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $1.15M.
  • Keudell/Morrison Wealth Management fully exited Invesco in Q2 2020, selling an estimated $927K.
  • Keudell/Morrison Wealth Management's ten largest holdings make up 27% of its $121M portfolio in Q2 2020.
  • Keudell/Morrison Wealth Management opened 16 new positions and closed 11 in Q2 2020.
  • Keudell/Morrison Wealth Management's portfolio value rose 18% quarter-over-quarter to $121M.

Based on Keudell/Morrison Wealth Management's 13F filing for Q2 2020, filed 14 Jul 2020.